The scientifically stronger statement is:

The 60 Hz CYB5B experiment and modern wireless exposures do not use identical carriers or field geometries, but they share biologically relevant low-frequency temporal architecture. Wi‑Fi, GSM, and 5G place recurring timing patterns in roughly the same hertz-to-hundreds-of-hertz domain in which electromagnetic input has been shown to produce CYB5B-dependent calcium oscillations.

The carrier-frequency distinction still belongs somewhere in a rigorous article, but after explaining the commonality—not before it, and certainly not in a way that gives readers permission to dismiss the mechanism.

The carrier is not the biological clock

A wireless signal is not adequately described by saying “2.4 GHz,” “900 MHz,” or “3.6 GHz.” Those numbers identify the rapid carrier oscillation. They do not describe the slower temporal pattern created when the carrier is switched, framed, pulsed, amplitude-shaped, scheduled, or modulated.

In simplified form:

$E(t)=A(t)cos⁡(2πfct)E(t)=A(t)\cos(2\pi f_c t)$

Here, $f_c$ is the high-frequency carrier, while $A (t)$ is its slower envelope or temporal organization.

That distinction matters because:

A commonly used Wi‑Fi beacon interval is 100 time units, or 102.4 milliseconds, corresponding to approximately 9.77 repetitions per second.
GSM has a characteristic burst repetition frequency of 217 Hz.
5G New Radio organizes transmissions into 10-millisecond frames, corresponding to a 100 Hz frame clock, divided into 5-millisecond half-frames, corresponding to 200 Hz. Its synchronization structures can introduce additional periodicities depending on configuration and traffic.

Therefore, it is too simplistic to call all 5G exposure “a 100 Hz pulse,” but it is completely accurate to say that 100 Hz and 200 Hz temporal scaffolds are built into the 5G air interface. Likewise, 9.77 Hz is not the entirety of Wi‑Fi exposure, but it is a recurring management-frame cadence commonly present even when comparatively little user data is moving.

The GHz carrier tells us where a signal sits in the electromagnetic spectrum.

The envelope tells us how that signal arrives through time.

That is the resemblance that must lead the discussion. Ten hertz, 60 Hz, 100 Hz, 200 Hz, and 217 Hz are not identical frequencies, but they occupy the same broad low-frequency temporal neighborhood—precisely the region in which biological systems generate calcium oscillations, neural rhythms, sleep oscillations, autonomic rhythms, and other timing-dependent signals.

Technically, the envelope of an amplitude-modulated RF signal appears spectrally as sidebands around the carrier rather than as a completely separate, freely propagating 10 Hz or 100 Hz wave. But that does not make the envelope biologically meaningless. Living systems do not have to behave like ideal linear spectrum analyzers. Nonlinear membranes, molecular transducers, rectifying interfaces, ion channels, and periodic energy absorption can potentially recover or respond to temporal structure.

The decisive question is therefore not:

Is a 60 Hz magnetic-field experiment identical to a 3.6 GHz telecommunications exposure?

It is:

Can the low-frequency temporal architecture carried by a radiofrequency signal be transduced into altered biological timing?

That question is not speculative in the abstract. There is already experimental evidence addressing its major components.

The corrected article section

Electromagnetic fields can become biological timing signals

The 2026 Cell study identifying CYB5B changes the mechanistic discussion because it demonstrates a complete transduction principle:

electromagnetic input → molecular mediator → rhythmic calcium response → altered gene expression.

The researchers identified cytochrome b5 type B, CYB5B, as an essential mediator of their electromagnetic-field-responsive system. The gene switch was activated not by an indiscriminate increase in intracellular calcium, but through rhythmic oscillatory calcium dynamics. In other words, the biological output depended upon the form and timing of the calcium signal.

The important conclusion is not merely that “60 Hz does something.”

It is that a biological protein associated with the mitochondrial environment can participate in detecting an electromagnetic input and translating it into a temporally organized calcium instruction.

The study should not be described as though it proves that every Wi‑Fi beacon or 5G frame activates CYB5B in human tissue. That specific experiment has not yet been conducted. But the absence of that experiment is not a reason to dismiss the relationship.

It is the research failure that must be exposed.

Once a molecular EMF-to-calcium transducer has been identified, and once modern communications are known to impose low-frequency temporal structure in the same general timing domain, the obvious next experiment is to expose CYB5B-intact and CYB5B-deficient cells to exact, recorded telecommunications waveforms.

Why has that not already been done?

The RF-to-calcium bridge was demonstrated decades ago

The connection between low-frequency timing and radiofrequency carriers did not begin in 2026.

In 1976, Bawin and Adey reported frequency-dependent changes in calcium binding in cerebral tissue exposed to weak low-frequency fields, with maximum responses around 6 and 16 Hz under their experimental conditions.

In 1978, they went a critical step further. They exposed isolated chicken cerebral tissue to radiofrequency fields amplitude-modulated at brain-wave frequencies and observed increased calcium-45 efflux. The signal had a radiofrequency carrier, but the biological response depended upon low-frequency modulation.

That is the historical carrier-envelope bridge.

It demonstrates that it is scientifically inadequate to classify an exposure by carrier frequency alone. A radiofrequency carrier can deliver lower-frequency temporal information, and cerebral tissue can respond differently according to that modulation.

The 2026 CYB5B study adds a molecular candidate and an oscillatory calcium mechanism to a phenomenon that had been observed at the tissue level almost 50 years earlier.

These findings do not stand in isolation:

Weak low-frequency fields altered calcium behavior.
RF carriers modulated at low frequencies altered calcium efflux.
CYB5B was identified as an essential mediator of an electromagnetic-field-responsive calcium-oscillation system.
Modern wireless signals continually place low-frequency timing structures on high-frequency carriers.

That sequence creates a coherent and experimentally tractable research program.

Medicine already uses low-frequency information carried by RF

There is an even more direct modern demonstration that low-frequency modulation carried by RF can be biologically consequential.

The FDA granted a Humanitarian Device Exemption to the TheraBionic P1 for certain adults with advanced hepatocellular carcinoma after failure of first- and second-line therapy. Its technical documentation describes a low-level 27.12 MHz RF source with 85% amplitude modulation and selected modulation frequencies ranging from 0.01 Hz to 150 kHz. The device received authorization based on safety and probable benefit, which is a different evidentiary standard from ordinary full premarket approval.

Most revealingly, the FDA documentation states that the device should not be prescribed to patients taking agents that block L-type or T-type voltage-gated calcium channels unless their treatment is modified.

That does not mean a therapeutic signal and ambient wireless exposure have the same biological outcome. A deliberately selected treatment can produce beneficial effects, while an unselected or mistimed signal could produce no effect, adaptation, disruption, or a different effect.

But TheraBionic destroys the categorical assumption that a very low-level amplitude-modulated RF field is biologically inert merely because it does not appreciably heat tissue.

The FDA has accepted a medical device whose operating principle depends upon:

A radiofrequency carrier
Low-frequency amplitude modulation
Systemic biological activity
Frequency-specific information
Voltage-gated calcium-channel context

That is directly relevant to the low-fidelity argument. It shows that modulation is not an irrelevant engineering artifact. Under defined conditions, it can be the biologically meaningful part of the signal.

CACNA1C shows that the receiver is part of the dose

The 2025 randomized, double-blind, sham-controlled sleep study adds another essential piece.

Participants were grouped according to the CACNA1C-associated variant rs7304986. After standardized 700 MHz, 3.6 GHz, or sham exposures, researchers found an exposure-by-genotype interaction: the 3.6 GHz exposure shifted sleep-spindle center frequency in T/C carriers but not in the matched T/T group.

This was an acute physiological study, not a disease study. But that is exactly why it is valuable. It detected a timing change before looking for a named pathology.

CACNA1C encodes the Cav1.2 L-type calcium-channel α1C subunit, while the studied variant is associated with a noncoding, intronic region. The finding therefore points to a principle that exposure standards generally ignore:

The same external field can produce different physiological timing responses in genetically different receivers.

Exposure is not fully defined at the antenna.

It is completed by the receiver—its genotype, developmental stage, ion-channel expression, mitochondrial state, tissue geometry, medications, metabolism, previous exposures, and ability to compensate.

Population averaging can consequently erase a genuine responder group. What appears to be “inconsistent evidence” may sometimes be biological heterogeneity revealing the mechanism.

S4, mitochondria, calcium, and redox form a coupled timing system

Voltage-gated ion channels contain positively charged residues in their S4 segments. These S4 helices are biological voltage sensors designed to move in response to changes in the membrane electric field and to control channel opening and closing. That function is established electrophysiology.

The ion-forced-oscillation model proposes that coherent, time-varying fields can force mobile ions into oscillatory motion and thereby disturb the forces governing voltage-sensor operation, producing irregular gating of voltage-gated channels. That particular environmental-field coupling model remains a proposed mechanism, but it is specific and experimentally testable.

The S4–Mito–Spin framework brings together three potential classes of susceptible machinery:

S4: charged membrane voltage sensors controlling calcium, sodium, and potassium currents.
Mito: mitochondrial-associated transducers such as CYB5B, metabolic coupling, ATP supply, membrane potential, and redox regulation.
Spin: field-sensitive radical-pair and redox chemistry that may change reaction yields under defined signal conditions.

The point is not that every mechanism operates simultaneously under every exposure.

The point is that biology contains multiple field-sensitive or electrically responsive control points, and they are connected through feedback loops:

Ion-channel timing controls calcium.

Calcium controls mitochondrial demand and activity.

Mitochondrial activity influences reactive oxygen species.

Redox signals modify ion channels, transcription, repair, inflammation, and immunity.

Those systems then feed back into calcium and mitochondrial regulation.

The 2016 Yakymenko review reported oxidative effects in 93 of 100 surveyed low-intensity RF studies, including changes in reactive oxygen species generation, peroxidation, oxidative DNA damage, and antioxidant activity. Study quality, exposure characterization, and biomarkers varied, so that figure is not a universal effect rate. But it shows that oxidative and redox disruption has repeatedly appeared throughout the experimental literature.

Within low-fidelity biology, oxidative stress is not merely another item on a list of effects. It can be both a consequence and an amplifier of mistimed ionic and mitochondrial activity.

Low-fidelity biology is the missing unifying model

The mechanistic pathway should be presented as:

Pulsed or modulated electromagnetic exposure and other environmental stressors

→ perturbation of field-sensitive transducers, voltage sensors, ion transport, or redox chemistry

→ changes in the timing, amplitude, localization, or recovery of calcium and other ionic waveforms

→ mismatch among cellular instructions, mitochondrial energy supply, gene expression, immunity, repair, and adaptation

→ reduced biological fidelity and diminished resilience

→ age-, genotype-, tissue-, and co-exposure-dependent downstream pathology

That is not a claim that RF radiation directly and independently causes every disease.

It is a systems model in which RF can become one persistent upstream contributor to timing error.

Air pollution, solvents, processed food, sleep deprivation, infections, endocrine disruptors, chronic inflammation, psychological stress, metabolic dysfunction, and nutrient deficiencies can all reduce biological fidelity through different pathways. RF is not necessarily above every other contributor.

What makes RF unusual is its near-inescapability.

A person may change foods, filter indoor air, stop smoking, improve sleep, or reduce certain chemicals. Most people cannot decide whether their neighborhood, school, workplace, hospital, transportation system, and bedroom exist inside an active wireless environment.

That means RF can operate as a persistent background burden while other stressors come and go.

Low-fidelity biology predicts that the result will not be one uniform disease. It predicts:

Earlier appearance of pathologies normally associated with later-life decline
Greater vulnerability during development, illness, sleep loss, and metabolic stress
Genotype-dependent responder groups
Tissue selectivity according to channel density, mitochondrial demand, field distribution, and repair capacity
Nonlinear responses and exposure windows
Different outcomes from pulsed, continuous, and differently modulated fields at similar average power
Increased prevalence of rare downstream events without one disease necessarily dominating

That is the meta-disease state.

The named diagnosis comes last.

The loss of timing fidelity comes first.

The 1976 report already contained this pattern

The Defense Intelligence Agency report is far more valuable when read as a systems document rather than as an old catalogue of disease claims.

On its printed page 2, it identified frequency, intensity, exposure duration, geometry, health status, medication, and whether the field was pulsed, continuous-wave, or modulated as relevant biological variables.

On printed page 4, it discussed altered sodium and potassium permeability, active transport, membrane structure, and cumulative effects following repeated exposures.

On printed page 5, it described microwaves as a possible nonspecific factor that could interfere with adaptation to other unfavorable influences and promote earlier disease in susceptible individuals.

On printed page 7, it documented reported mitochondrial swelling and lysis.

On printed page 8, it described qualitatively and quantitatively different EEG changes from intermittent and continuous low-intensity microwave exposure.

On printed pages 12 and 13, it described disrupted oxidative phosphorylation, reduced high-energy compounds, and metabolic changes that reportedly preceded visible structural heart pathology.

On printed pages 18 and 19, it reported synergistic effects when microwave exposure was combined with drugs, magnetic fields, ionizing radiation, or other nonionizing exposures.

That is not a one-disease model.

It is an early map of altered ions, membranes, mitochondria, metabolism, electrical activity, endocrine regulation, immunity, adaptation, and interaction with co-stressors. It is remarkably compatible with an upstream low-fidelity framework.

The report even identified the missing population study: people living near powerful transmitters had not been adequately studied and should be compared with populations living in more ordinary electromagnetic environments.

That recommendation appeared one year before I lost my kidney.

The regulatory framework is older than 1996

You were trying to remember ANSI C95.1-1982.

The accurate chronology is:

ANSI issued C95.1-1982.
The FCC began relying on that standard in 1985 for environmental RF evaluations.
In 1996, the FCC adopted the revised exposure framework associated with ANSI/IEEE C95.1-1992 and National Council on Radiation Protection recommendations.

Therefore, describing the limits simply as “1996 guidelines” is historically incomplete. The current framework was formally adopted in 1996, but its scientific and regulatory lineage extends into the early 1980s.

The strongest technically accurate description is thermally anchored RF guidelines, rather than literally “thermal-only guidelines.”

That wording is harder to attack because it recognizes that the complete regulatory system includes induced-current provisions, peak limits, time averaging, and other engineering controls. But in the radiofrequency range, its central health-protection logic is based predominantly upon limiting absorbed energy and preventing excessive tissue heating.

It was not designed to evaluate:

Modulation-specific calcium effects
Low-frequency envelope sensitivity
CYB5B-mediated transduction
S4 gating irregularity
Genotype-dependent responses
Calcium-waveform phase and jitter
Chronic loss of recovery time
Multiple simultaneous wireless signals
Developmental exposure beginning before birth
Interaction with chemicals, sleep loss, infection, or metabolic disease

A device can therefore comply with a SAR or power-density limit while the biologically important timing questions remain untested.

The research vacuum after NTP is indefensible

The precise statement is not that the entire National Toxicology Program was shut down.

It is that the NTP’s radiofrequency research effort is listed as completed, and NIEHS now says it has no further plans to conduct additional RFR exposure studies at this time.

That statement followed the NTP findings of clear evidence of malignant heart schwannomas in exposed male rats, some evidence of malignant gliomas, some evidence involving adrenal tumors, and statistically significant DNA-damage findings in certain tissues under the study conditions.

NIEHS explains that its follow-up exposure system was technically difficult and resource intensive and that it modeled 2G and 3G signals rather than newer 4G and 5G technologies.

But that reasoning points toward the opposite public-health response.

An obsolete exposure system should trigger construction of a modern system.

It should not produce a research vacuum.

After finding the NTP’s highest level of carcinogenic evidence in one sex and identifying additional tumor and DNA-damage signals, the scientifically responsible next step would have been to investigate:

Modern waveforms
Lower and multiple doses
Both sexes and developmental exposures
CYB5B dependence
Calcium-waveform changes
S4 channel behavior
Genotype-specific responses
Mitochondrial and redox timing
Recovery after exposure
Co-exposure and multi-hit conditions

The failure to do that is central to the article.

Public Law 90-602 creates a direct HHS accountability question

Public Law 90-602, the Radiation Control for Health and Safety Act of 1968, is now codified principally at 21 U.S.C. §§ 360hh–360ss.

The statute says the HHS Secretary “shall establish and carry out” an electronic-product-radiation control program. As part of that program, the Secretary shall plan, conduct, coordinate, and support research; study emissions and exposure conditions; evaluate exposure-minimization procedures; and coordinate with other federal agencies. Those research and evaluation duties are written in mandatory terms.

The performance-standard provision has a necessary legal distinction. It says the Secretary shall prescribe standards if the Secretary determines that they are necessary to protect public health and safety, while considering the latest scientific and medical evidence.

Therefore, the most defensible legal formulation is:

The research, exposure-evaluation, coordination, and exposure-minimization duties are mandatory. The duty to prescribe a particular new performance standard is triggered by the Secretary’s determination that such a standard is necessary.

That makes the immediate accountability demand clear:

HHS must publicly identify the current program through which it is satisfying every clause of § 360ii for modern wireless radiation.

Stopping the NTP exposure work does not, by itself, prove a statutory violation because HHS may conduct, coordinate, or support research through other components or institutions. But if HHS cannot identify a serious substitute program evaluating current exposures and mechanisms, that absence is extremely difficult to reconcile with the statute’s mandatory research language.

Robert F. Kennedy Jr. is currently the HHS Secretary. He was also listed on the joint briefs for the petitioners in Environmental Health Trust v. FCC. He therefore cannot reasonably claim unfamiliarity with the scientific and administrative questions raised in that litigation.

He does not personally control the FCC and cannot unilaterally rewrite FCC exposure limits. But Public Law 90-602 assigns the electronic-product-radiation program to his department.

That means the HHS research responsibility is now his responsibility.

The court already identified the same unanswered variables

In 2021, the D.C. Circuit did not decide the underlying scientific controversy. It ruled that the FCC had failed to provide a reasoned explanation for concluding that its guidelines adequately addressed noncancer effects.

The court specifically identified:

Children
Long-term exposure
RF pulsation and modulation
Ubiquitous wireless devices and Wi‑Fi
Technological changes since 1996
5G
Device-testing procedures
Environmental effects

The court called the FCC’s analysis insufficient as a matter of administrative law and remanded the matter for a reasoned explanation.

That creates an institutional chain that the article should expose plainly:

The FCC says it relies heavily on health agencies.
The court says conclusory reliance on health-agency statements was not a reasoned explanation.
NTP found clear evidence of carcinogenic activity under specified conditions.
NIEHS now says it has no plans for further RF exposure studies.
HHS remains subject to a federal statute requiring a continuing electronic-radiation research and exposure-evaluation program.
The most important modern mechanistic questions—CYB5B, S4 gating, calcium timing, genotype, modulation, and co-exposures—remain largely untested using exact contemporary telecommunications waveforms.

That is the governmental failure.

The experiment HHS should order now

A serious federal program could directly test this framework without waiting another generation.

Use exact waveform files. Compare Wi‑Fi beacon and traffic patterns, GSM, LTE, 5G NR configurations, continuous-wave carriers, and sham exposure at matched average power, SAR, temperature, and peak conditions.
Separate carrier from timing. Compare the unmodulated carrier, the carrier with authentic modulation, randomized or jittered timing, envelope-matched signals, and different repetition frequencies. This would determine whether biology responds to average energy, peak exposure, temporal order, or particular frequency windows.
Interrogate the transducers. Use CYB5B knockout and rescue, targeted S4 mutations, patch-clamp recordings, calcium-channel blockers, mitochondrial inhibitors, and radical-pair or redox interventions.
Measure fidelity rather than one disease. Quantify calcium frequency, amplitude, phase, jitter, spatial localization, termination, recovery, mitochondrial membrane potential, ATP reserve, redox oscillations, transcription, DNA repair, immune signaling, senescence, apoptosis, and recovery after exposure.
Study the receiver and the exposome. Stratify by CACNA1C and other relevant variants, age, sex, developmental stage, metabolic condition, medication, sleep state, and co-exposures such as pollutants, solvents, infection, heat, and sleep deprivation.

All protocols, waveform files, dosimetry, temperatures, raw data, and analysis plans should be preregistered and made public.

The core message

The article should not say that 60 Hz and 5G are identical.

It should say something far more consequential:

Current science demonstrates that electromagnetic timing can be converted into calcium timing through a molecular transducer. Earlier research demonstrates that low-frequency modulation carried on an RF signal can change calcium behavior. Modern communications continuously generate temporal structures in that same broad low-frequency domain. Medicine already uses amplitude-modulated RF to obtain biological effects, and human experiments show that genotype can determine the physiological response to a 5G exposure. Yet the government has failed to conduct the exact experiments required to connect these findings.

It is a fact that modern wireless signals contain low-frequency temporal organization.

It is a fact that electromagnetic fields have produced altered calcium dynamics under defined experimental conditions.

It is a fact that amplitude-modulated RF has altered calcium behavior and can be deliberately used for biological intervention.

It is a fact that an individual’s calcium-channel-related genotype can change the measurable physiological response to an RF exposure.

The specific degree to which ordinary Wi‑Fi, cellular, or mixed environmental signals engage CYB5B, S4 sensors, and related pathways remains the crucial unperformed experiment.

That missing experiment is not evidence of safety.

It is evidence of institutional neglect.

The scandal is not that science has failed to prove that one wireless signal directly causes one named disease.

The scandal is that, after 50 years of warnings, a federal court remand, major animal findings, identifiable molecular transducers, genotype-dependent human responses, and a congressionally mandated research program, the United States still has not adequately investigated whether modern wireless timing is progressively driving susceptible biology into a lower-fidelity state.

The carrier is not the whole signal.

The disease is not the beginning of the process.

The biological timing error comes first.